» Articles » PMID: 34441309

Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases

Overview
Specialty Radiology
Date 2021 Aug 27
PMID 34441309
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The oral cavity is host to a complex and diverse microbiota community which plays an important role in health and disease. Major oral infections, i.e., caries and periodontal diseases, are both responsible for and induced by oral microbiota dysbiosis. This dysbiosis is known to have an impact on other chronic systemic diseases, whether triggering or aggravating them, making the oral microbiota a novel target in diagnosing, following, and treating systemic diseases. In this review, we summarize the major roles that oral microbiota can play in systemic disease development and aggravation and also how novel tools can help investigate this complex ecosystem. Finally, we describe new therapeutic approaches based on oral bacterial recolonization or host modulation therapies. Collaboration in diagnosis and treatment between oral specialists and general health specialists is of key importance in bridging oral and systemic health and disease and improving patients' wellbeing.

Citing Articles

An Integrated Deep Learning Model with EfficientNet and ResNet for Accurate Multi-Class Skin Disease Classification.

Alruwaili M, Mohamed M Diagnostics (Basel). 2025; 15(5).

PMID: 40075797 PMC: 11898587. DOI: 10.3390/diagnostics15050551.


Dysbiosis of Oral Microbiome: A Key Player in Oral Carcinogenesis? A Critical Review.

Devaraja K, Aggarwal S Biomedicines. 2025; 13(2).

PMID: 40002861 PMC: 11852717. DOI: 10.3390/biomedicines13020448.


Differential Oral Microbiota and Serum Cytokine Signatures in Age-Grouped Patients with Marfan Syndrome.

Ordaz-Robles E, Soto M, Hernandez-Ruiz P, Escalona-Montano A, Constantino-Jonapa L, Amedei A Biomedicines. 2025; 13(2).

PMID: 40002744 PMC: 11853651. DOI: 10.3390/biomedicines13020330.


Recurrent Pyogenic Granuloma Progressing to Calcifying Fibroblastic Granuloma in an Adolescent Male Athlete: A Case Report.

Porto Barboza E, Panariello B, Araujo D, Rodrigues D, Manibo A Cureus. 2025; 17(1):e77794.

PMID: 39981483 PMC: 11842033. DOI: 10.7759/cureus.77794.


The Role of Oral Biomarkers in the Assessment of Noncommunicable Diseases.

Saenz-Ravello G, Hernandez M, Baeza M, Hernandez-Rios P Diagnostics (Basel). 2025; 15(1.

PMID: 39795606 PMC: 11719684. DOI: 10.3390/diagnostics15010078.


References
1.
Brito F, Zaltman C, Carvalho A, Fischer R, Persson R, Gustafsson A . Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis. Eur J Gastroenterol Hepatol. 2012; 25(2):239-45. DOI: 10.1097/MEG.0b013e32835a2b70. View

2.
Lamster I, Pagan M . Periodontal disease and the metabolic syndrome. Int Dent J. 2016; 67(2):67-77. PMC: 9376683. DOI: 10.1111/idj.12264. View

3.
Jeffcoat M, Jeffcoat R, Gladowski P, Bramson J, Blum J . Impact of periodontal therapy on general health: evidence from insurance data for five systemic conditions. Am J Prev Med. 2014; 47(2):166-74. DOI: 10.1016/j.amepre.2014.04.001. View

4.
Teughels W, Newman M, Coucke W, Haffajee A, van der Mei H, Haake S . Guiding periodontal pocket recolonization: a proof of concept. J Dent Res. 2007; 86(11):1078-82. DOI: 10.1177/154405910708601111. View

5.
Thomas C, Dimmock M, Gilletta de Saint-Joseph C, Barres B, Paul C, Cousty S . How Oral Specialists Can Help Diagnose and Manage Extra-Digestive Inflammatory Bowel Disease Complications. Case Rep Gastroenterol. 2021; 15(1):276-281. PMC: 7989805. DOI: 10.1159/000513156. View